## Glioblastoma (Grade IV) vs. Anaplastic Astrocytoma (Grade III) ### WHO 2021 Grading Distinction The critical feature that defines a grade IV glioblastoma and distinguishes it from grade III anaplastic astrocytoma is the **presence of necrosis and/or microvascular proliferation**. These are mandatory criteria for grade IV classification. ### Histopathological Comparison | Feature | Grade III Anaplastic Astrocytoma | Grade IV Glioblastoma | |---------|---------|----------| | **Mitotic figures** | Frequent | Frequent | | **Cellularity** | Marked | Marked | | **Nuclear atypia** | Moderate to severe | Severe | | **Necrosis** | Absent | **Present (mandatory)** | | **Microvascular proliferation** | Absent | **Present (mandatory)** | | **Vascular proliferation** | May be present | Prominent | **Key Point:** Glioblastoma is defined by the presence of **tumor necrosis** and/or **microvascular (endothelial) proliferation**. Either one is sufficient for grade IV classification. These features are absent in grade III anaplastic astrocytoma. ### Pathological Basis **High-Yield:** Necrosis in glioblastoma reflects: 1. Rapid tumor growth outpacing blood supply 2. Hypoxia-driven tumor progression 3. Activation of HIF-1α pathway 4. Increased angiogenesis as a compensatory response Microvascular proliferation (abnormal endothelial cell proliferation) is a hallmark of grade IV tumors and indicates aggressive angiogenesis. ### Clinical Correlation **Clinical Pearl:** The presence of necrosis on imaging (ring enhancement with central necrosis) or histology is a strong predictor of worse prognosis and defines the tumor as glioblastoma. Patients with grade IV disease have median survival of 12–15 months, compared to 2–3 years for grade III. ### Why Other Features Don't Distinguish Grade III from IV **Warning:** - **Nuclear pleomorphism** is present in both grade III and IV — not a discriminator - **Marked cellularity and mitotic figures** are present in both grades — not specific to grade IV - **Ring enhancement on MRI** is a radiological sign of necrosis but reflects the underlying pathology; the pathology itself (necrosis) is the true discriminator ```mermaid flowchart TD A[Diffuse Astrocytoma with IDH mutation]:::outcome --> B{Mitotic figures present?}:::decision B -->|No| C[Grade II Diffuse Astrocytoma]:::outcome B -->|Yes| D{Necrosis or microvascular proliferation?}:::decision D -->|No| E[Grade III Anaplastic Astrocytoma]:::outcome D -->|Yes| F[Grade IV Glioblastoma]:::urgent ``` [cite:Robbins 10e Ch 28] 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.